Linyu Wei

机构：Xidian University, Huazhong University of Science and Technology · ORCID：0000-0003-4773-2228

发表论文 40 篇 · 总被引 670 次 · h-index 16

代表论文

• A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies (2021 · Signal Transduction and Targeted Therapy · 被引 74)
• Adenosine Triphosphate Release and P2 Receptor Signaling in Piezo1 Channel-Dependent Mechanoregulation (2019 · Frontiers in Pharmacology · 被引 68)
• ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics (2018 · Neuroscience & Biobehavioral Reviews · 被引 47)
• Increasing the TRPM2 Channel Expression in Human Neuroblastoma SH-SY5Y Cells Augments the Susceptibility to ROS-Induced Cell Death (2019 · Cells · 被引 46)
• Tau inhibits PKA by nuclear proteasome‐dependent PKAR2α elevation with suppressed CREB/GluA1 phosphorylation (2019 · Aging Cell · 被引 42)
• TRPM2 channel: A novel target for alleviating ischaemia‐reperfusion, chronic cerebral hypo‐perfusion and neonatal hypoxic‐ischaemic brain damage (2019 · Journal of Cellular and Molecular Medicine · 被引 29)